Susquehanna International Group, LLP Moon Lake Immunotherapeutics Call Options Transaction History

Susquehanna International Group, LLP

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$40.15 - $55.4 $1.29 Million - $1.78 Million	-32,200 Reduced 63.51%	18,500 $932,000
Q2 2024 Aug 15, 2024	BUY	$38.43 - $48.6 $318,969 - $403,380	8,300 Added 19.58%	50,700 $2.23 Million
Q1 2024 May 07, 2024	BUY	$43.78 - $63.86 $455,312 - $664,144	10,400 Added 32.5%	42,400 $2.13 Million
Q4 2023 Feb 14, 2024	SELL	$36.35 - $63.02 $36,350 - $63,020	-1,000 Reduced 3.03%	32,000 $1.93 Million
Q3 2023 Nov 14, 2023	BUY	$48.35 - $61.26 $1.6 Million - $2.02 Million	33,000 New	33,000 $1.88 Million

124

58.2M

52.2K

38K

Ticker MLTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,925,600
Market Cap $2.01B
Description
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.